anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Callout

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 96,741
Current window 74,041-74,070
Pages 3,225
Rows per page 30
Component: Calloutclear collectionreset all
18 30 60

Component

74,041-74,070 of 96,741

filter-aware
152
The slide uses a 'villain_critique' structure to undermine the company's core value proposition by citing internal dissent.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller 1 hit
153
The slide uses direct quotes from former employees to validate the thesis that the product is difficult to use.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller 1 hit
154
The slide uses direct quotes to validate the claim of high operational burden.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller 1 hit
155
Uses direct quotes from former employees to build a case against the company's value proposition.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller 1 hit
156
The slide uses expert testimony to frame Abcellera as a disruptive competitor to BLI.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller 1 hit
157
Includes direct quotes from former BLI scientists as evidence of competitive displacement.Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller 1 hit
158
Uses testimonial-style quotes to build a case against the subject company (BLI).Berkeley Lights (BLI) · Scorpion Capital
Research note Short seller 1 hit
01
Slide 1
This is a formal legal/regulatory document cover letter/introductory page.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller 1 hit
02
The slide uses a comparative historical analogy (Seldane) to frame the current safety concerns as a 'tragedy in the making'.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · ComplicationLoop · Pattern Hunter1 hit
03
This slide appears to be part of a Citizen Petition or regulatory filing challenging the safety profile of a drug.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · ComplicationLoop · Pattern Hunter1 hit
04
This appears to be a page from a regulatory petition or legal filing challenging the approval of a drug.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · ComplicationLoop · Pattern Hunter1 hit
05
This is a page from a Citizen Petition document.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · EvidenceLoop · Cost Of Inaction1 hit
06
This is a text-heavy regulatory filing page. It uses anecdotal evidence from prescriber interviews and social media to argue that current warnings are insufficient.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · EvidenceLoop · Cost Of Inaction1 hit
07
The slide serves as a foundational disclosure for a regulatory filing, establishing the credibility and scope of the petitioner's investigative work.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · Executive Summary1 hit
08
This appears to be a page from a legal or regulatory petition (Citizen Petition) detailing allegations against a drug product.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · Appendix Disclosure1 hit
09
This is a standard legal/regulatory filing signature page.Harmony Biosciences (HRMY) · Kir Kahlon
Regulatory filing Short seller Beat · Appendix Disclosure1 hit
01
Slide 1
The slide uses highly aggressive, inflammatory language characteristic of activist short-seller reports.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller 1 hit
03
The slide uses aggressive, accusatory language typical of short-seller activist decks.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller 1 hit
07
The slide uses aggressive, accusatory language to frame the company as a 'colossal fraud'.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Villain Critique1 hit
08
Includes a link to the China Hustle documentary trailer and a historical stock chart of Sino-Forest (TRE.TO) showing its collapse.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Villain Critique1 hit
09
The slide uses a combination of a table from a SPAC prospectus and screenshots of LinkedIn and corporate registry filings to build a case of a 'China Hustle-type scam'.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Villain Critique1 hit
10
Uses investigative field research to challenge the legitimacy of revenue sources.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Villain Critique1 hit
11
Uses the 'iceberg' metaphor to suggest deeper fraud. Includes a screenshot of a press release and a website as evidence.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Villain Critique1 hit
12
The slide uses red circles and arrows to highlight specific data points in the SEC filing to support the narrative of undisclosed related-party transactions.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Villain Critique1 hit
13
The slide uses a red box to highlight Ginkgo Bioworks as the most expensive company in the dataset.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Villain Critique1 hit
14
The slide uses a table of current shareholders to highlight the 'smart money' concentration.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Villain Critique1 hit
15
Uses specific examples of financial fraud and regulatory trouble to counter the 'halo effect' of Tiger Cub investment.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Villain Critique1 hit
16
The slide uses a narrative structure to link an investor (Viking) to questionable related-party transactions involving the target company (Ginkgo).Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Villain Critique1 hit
18
The slide uses a combination of primary source excerpts and critical commentary to frame the Ferment Fund as a 'slush fund' rather than a legitimate investment vehicle.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Villain Critique1 hit
19
The slide uses screenshots of a LinkedIn profile and the Ferment website to build a case of related-party transactions.Ginkgo Bioworks (DNA) · Scorpion Capital
Activist deck Short seller Beat · Villain Critique1 hit